Startups
Portal Innovations is a venture development engine focused on early stage life science enterprises.
Overview
Location
United States, Illinois, Chicago
Employees
11-50
Mentions in press and media 15
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jun 22, 2026 | Syntax Bio Raises $14.4 Million Series A And Announces Leadership Appointments | Syntax Bio announced an expanded Series A round and several leadership appointments across its executive team, board of directors, and scientific advisory board. The expanded round brings Syntax Bio’s Series A to $14.4 million and total fun... |
| Jun 22, 2026 | Syntax Bio Expands Series A to $14.4M | Syntax Bio, a Chicago, IL-based synthetic biology company programming new cell therapies, expanded its Series A to $14.4M. The expanded round saw participation from Astellas Venture Management, Illumina Ventures, DCVC Bio, Civilization Vent... |
| Nov 8, 2025 | Biohm Technologies Expands Biotech R&D Footprint with New Lab Space at Portal Innovations in Atlanta | Biohm Technologies, a microbiome innovation company known for advancing both the bacterial and fungal sides of gut health, announced today that it has opened laboratory space at Portal Innovations in Atlanta's Science Square, a leading hub ... |
| Oct 7, 2025 | Bluefors Opens Shared Lab Facility at the UChicago Science Incubator, Expands Bluefors Lab Chicago | Bluefors Opens Shared Lab Facility at the UChicago Science Incubator, Expands Bluefors Lab Chicago Tue, Oct 07, 2025 15:00 CET Report this content Helsinki, Finland & Chicago, IL, USA – October 7, 2025: Bluefors, the world leader in cry... |
| Jul 9, 2025 | Syntis Bio Secures $38M Series A, Accelerates Oral Therapy Pipeline | Syntis Bio, a Boston biopharma, secured $38M Series A funding led by Cerberus Ventures. An additional $5M from NIH non-dilutive grants was also obtained. This substantial capital propels the development of oral therapies for obesity, diabet... |
| Jul 7, 2025 | Syntis Bio raises $38 million | Syntis Bio, Syntis Bio Founded: 2022 Headquarters: Boston, Massachusetts, United States Total Funding: $53.37M See full company profile "> a Boston-based obesity, diabetes, and rare diseases oral therapies developer, announced the c... |
| Apr 25, 2025 | Grove Biopharma: Pioneering a New Era in Therapeutics with $30 Million Series A Financing | In the bustling world of biotechnology, innovation is the lifeblood that fuels progress. Grove Biopharma, a Chicago-based company, has recently secured $30 million in Series A financing, a significant leap towards revolutionizing drug devel... |
| Apr 23, 2025 | Grove Biopharma Closes $30 Million Series A Financing to Advance Bionic Biologics™, a New Therapeutic Modality | – Proprietary Platform Integrates Principles of Biologic and Synthetic Design, Producing Drug Candidates that Selectively Disrupt or Degrade Previously Intractable Intracellular Targets – – Experienced, Multidisciplinary Team Well-Positione... |
| Nov 13, 2024 | Houston innovator builds tech to revolutionize pipeline safety, efficiency | After working for years in the downstream energy industry where safety and efficiency were top priorities, Dianna Liu thought there was a way technology could make a huge difference. Despite loving her company and her job, she took a leap o... |
Show more
Reviews 0
FAQ about Portal Innovations
What has the press written about Portal Innovations?
Parsers VC has collected 15 articles mentioning Portal Innovations, among them “Syntax Bio Raises $14.4 Million Series A And Announces Leadership Appointments” (Jun 22, 2026) and “Syntax Bio Expands Series A to $14.4M” (Jun 22, 2026).
Is Portal Innovations still active?
Yes, Portal Innovations is active; its latest activity on Parsers VC dates from Aug 20, 2026.